Dettaglio FAD:

RESPIRAMI - Recent Advances on Air pollution and Health

Data:
28/01/2021 - 28/01/2022
ECM:
Crediti:
Piattaforma:

Nuova data:
28/01/2021 - 28/01/2022


Target: Respiratory
Scientific Responsible: Francesco Forastiere, Michal Krzyzanowski, Sergio Harari,
and Pier Mannuccio Mannucci

Italian CME Crredit: 4 


INTRODUCTION AND RATIONALE I SESSION

The human coronavirus disease 2019 (COVID_19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that in the first six months of 2020 spread to at least 200 countries of the world. The first epicenter was in January the city of Wuhan and caused in the whole China 84.000 infected cases and 4600 deaths. The first epicenter in Europe was Italy in February-March and particularly the Northern region of Lombardy, causing in whole country approximately 240.000 infections and 35.000 fatalities. Other heavily affected European countries were Spain, France, the UK and Russia. COVID-19 then spread to the Americas with a first epicenter in April in New York City, causing in the USA at least 2.000.000 infections and 115.000 fatalities. In the frame of this dramatic global scenario there is still considerable uncertainty pertaining to the mechanisms of viral spread and the factors that contribute to the different degree of disease severity. It is plausible that an environmental risk factor such as ambient air pollution characterized by a high population attributable fraction plays a key role in increasing the likelihood of spread and severe clinical outcomes in COVID-19, because ambient air pollution has an adverse impact on global morbidity and mortality through components such as fine particulate matter (PM2.5), nitrogen dioxide (NO2) and ozone (O3). They affect human health by producing oxidative stress and inflammation, that is turn cause damage on the respiratory, cardiovascular and immune systems definitely involved in COVID-19. With this background, it is biologically plausible that the degree and duration of exposure to air pollution might have harmful effects on the occurrence and clinical course of COVID-19. With these gaps of knowledge this webinar is planned to contribute to a better understanding on whether or not short- and long-term exposure to ambient air pollution influences the spread and clinical manifestations of COVID-19. It is hoped that this initiative will update on the latest evidence and help to support and foster globally public health interventions targeted to protect people living in heavily polluted regions through efforts aimed to lower the emissions of the harmful components of ambient air. 


RATIONALE OF SESSION II and III

The Respirami 3 conference in Milan in January 2019 (http://www.ilpolmone.it/congresso-respirami-milano-2019) was a remarkable event with a large participation of international scientists, professionals of the health care sector and environmental protection agencies, all providing an interesting update of the research on air pollution. Since then, research on the health effects of air pollution have progressed considerably. The Health Effects Institute, the European Respiratory Society (ERS), the World Health Organization (WHO), and the International Society for Environmental Epidemiology (ISEE) organized a joint meeting in Brussels, Belgium, on January 21-22, 2020 with the aim to review the latest science on major pollutants, focusing on particulate matter 2.5 μm or less in diameter (PM2.5) and nitrogen dioxide (NO2), to help evaluate the need for updating Europe’s air quality policies. A number of important scientific and policy questions about the causal links between air pollution and health, its effects at low levels of exposure, the relative contributions of different sources or constituents, and ultimately the question of how to achieve the most health benefits most cost-effectively were considered.The present initiative will update Italian an International professionals on the latest evidence and provide an interesting platform for future research applications and project.

Area riservata

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Menarini Pills of Art”
Il nuovo progetto multimediale di Menarini legato al mondo dell’arte



Comunicato Stampa:
RESTYLING DI MINUTI



Minuti Menarini Online

Oltre all’Edizione Scientifica, la Fondazione cura la pubblicazione dell’edizione artistica di “Minuti Menarini” rivolta a tutti i medici e farmacisti italiani che amano l’arte.



Fondazione Internazionale Menarini



ISCRIVITI ALLA NEWSLETTER

Ricevi ogni mese le informazioni sulle attività della Fondazione Internazionale Menarini.

VGFM DATA-LAYER

Fondazione Internazionale Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484